Tern PLC (AIM:TERN) shares surged some 30% higher, to 1.18p, after it increased exposure to Talking

https://www.bloomberg.com/news/articles/2026-05-18/merck-starts-seven-part-high-grade-bond-sale-to-f

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Cana

Merck retains a 'strong buy' rating, driven by proactive oncology pipeline expansion to offset KEYTR

Merck  MRK is set to report its first-quarter 2026 earnings on April 30, before market open. The Zac

Designation for the treatment of adult patients with Philadelphia chromosome-positive chronic myeloi

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the wa

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Cana

Inhibrx explores spin-off of INBRX-106 amid Big Pharma interest, with potential valuation exceeding

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan

All told, the transaction is valued at around $6.7 billion. If all goes well, it'll close this quart

The deal consideration is $53.00 per share in cash for an approximate equity value of $6.7 billion.

Merck cuts Terns deal price after TERN-701 data review, while maintaining interest amid competition

Merck begins tender offer for Terns at $53 per share as part of its planned acquisition announced in

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Cana

MILWAUKEE, April 07, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Terns (NASDAQ: TERN) for po

Capricorn Fund Managers Ltd bought a new stake in shares of Terns Pharmaceuticals, Inc. (NASDAQ: TER

FOSTER CITY, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the

Infinimmune, Merck ink deal to develop human-derived antibodies using the Anthrobody platform. See t

Pre-Market Stock Futures: Futures are trading higher this morning after reports are circulating that

Top Wall Street analysts changed outlook on top names. For all changes, including upgrades/downgrade

Pre-Market Stock Futures: Futures are trading lower as we prepare to end another up-and-down week, a

MRK's $6.7B Terns buyout is set to add a promising leukemia drug candidate, boosting its oncology pi

Wall Street analysts changed outlook on top names. See full changes on analyst ratings page. UNFI st

E. Ohman J or Asset Management AB lessened its position in shares of Terns Pharmaceuticals, Inc. (NA

Shares of Terns Pharmaceuticals, Inc. (NASDAQ: TERN - Get Free Report) reached a new 52-week high du

Wall Street analysts changed their outlook on top names. Check analyst ratings page for upgrades, do

Merck to buy Terns for $6.7 billion as Keytruda patent risk nears, boosting leukemia pipeline; analy

Terns' lead candidate TERN-701 is an investigational oral allosteric BCR::ABL1 tyrosine kinase i

Merck is reportedly nearing a $6 billion acquisition of Terns Pharmaceuticals to strengthen its onco

Eli Lilly's obesity drug data misses targets, boosting shares of Novo Nordisk, Viking, Structure

https://www.bloomberg.com/news/articles/2024-12-13/ozempic-craze-appears-to-be-curbing-us-obesity-ep

https://www.medscape.com/viewarticle/ada-advises-against-using-compounded-glp-1-ra-medications-2024a

https://www.statnews.com/2024/10/30/novo-nordisk-ozempic-wegovy-fda-available-or-in-shortage/

Eli Lilly and Novo Nordisk face selloff as new weight-loss drugs threaten dominance. Shares of both